News on this topic

Paid articlePaywall Abbott To Complete $21B M&A Deal For Exact Sciences - What Investors Should Know: Exact Sciences Corporation stock surged after Abbott Laboratories announces a ...
seekingalpha.com/article/4846214-abbott-to-complete-21bn-m-and-a-deal-for-exact-sciences-what-investors-should-know

Paid articlePaywall Exact Sciences likely needs to see over $100/share in takeover - analyst: Exact Sciences (EXAS) surges on Abbott takeover talks. Analysts see a $100+ share value ...
seekingalpha.com/news/4524064-exact-sciences-likely-needs-to-see-over-100-share-in-takeover

Paid articlePaywall Exact Sciences jumps on report Abbott nears takeover: Exact Sciences shares surge 28% amid reports of a potential Abbott takeover. Get the latest updates on this ...
seekingalpha.com/news/4524039-exact-sciences-jumps-on-report-abbott-nears-takeover
Similar to This
Previous

Paid articlePaywall Commerzbank: Shareholders turn away – “The investment case is broken”: Due to the takeover by Unicredit, the outlook for Commerzbank shareholders is clouding ...
handelsblatt.com/finanzen/banken-versicherungen/banken/commerzbank-anteilseigner-wenden-sich-ab-der-investment-case-ist-kaputt/100263991.html

Biggest stock movers Wednesday: NFLX, SPCX, ABT, and more: Stock futures edge up as investors parse earnings, AI capex worries, and Middle East tensions.
seekingalpha.com/news/4655010-biggest-stock-movers-wednesday-nflx-spcx-and-more

Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTech: Stryker (SYK) stock and Abbott (ABT) stock gain as Barclays picked them among its ...
seekingalpha.com/news/4651117-stryker-abbott-among-new-overweights-barclays

Why Abbott Labs CEO Robert Ford is betting $2M on ABT dip | ABT: Abbott Labs stock hit a 52-week low after an earnings miss, but CEO Robert Ford isn't flinching ...
thestreet.com/investing/stocks/abbott-labs-ceo-robert-ford-makes-2m-insider-buy-as-stock-sinks

Wall Street Brunch: Megacaps And The Fed: Apple Microsoft and Meta lead a packed earnings week. Fed decision looms as Powell faces White House investigation ...
seekingalpha.com/article/4862511-wall-street-brunch-megacaps-and-the-fed

Paid articlePaywall Abbott Laboratories: The Market's Overreaction Is The Long-Term Investor's Opportunity
seekingalpha.com/article/4862051-abbott-laboratories-market-overreaction-is-long-term-investors-opportunity

Paid articlePaywall Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise
seekingalpha.com/article/4855598-abbott-laboratories-shrugs-off-tariffs-and-china-headwinds-with-7-percent-dividend-raise

Abbott is buying Exact Sciences. Here’s why
modernhealthcare.com/medical-devices/mh-abbott-laboratories-exact-sciences-robert-ford/

Abbott bets on cancer screening with $23 billion Exact Sciences deal: Abbott will buy cancer test maker Exact Sciences in a deal valued at up to $23 billion ...
reuters.com/business/healthcare-pharmaceuticals/abbott-bolsters-diagnostics-portfolio-with-up-23-billion-buyout-exact-sciences-2025-11-20/

Abbott is weighing takeover of Exact Sciences, Bloomberg News reports: Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test ...
reuters.com/business/healthcare-pharmaceuticals/abbott-is-weighing-takeover-exact-sciences-bloomberg-news-reports-2025-11-19/

Here are the major earnings before the open Wednesday: Major earnings expected before the bell on Wednesday include:Bank of America Corporation (BAC)ASML Holding ...
seekingalpha.com/news/4503932-here-are-the-major-earnings-before-the-open-wednesday

Paid articlePaywall Abbott signals confidence in sustaining high single-digit sales and double-digit EPS growth into 2026, led by innovation and new product launches
seekingalpha.com/news/4504384-abbott-signals-confidence-in-sustaining-high-single-digit-sales-and-double-digit-eps-growth

Abbott Laboratories (ABT) Q2 2025 Earnings Call Transcript: Abbott Laboratories (NYSE:ABT) Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ...
seekingalpha.com/article/4802045-abbott-laboratories-abt-q2-2025-earnings-call-transcript

Paid articlePaywall Oxford Nanopore: Ultra-Long Reads In A Short-Term Slump: Oxford Nanopore shares declined 33% due to slower growth, but positive prospects and unique product ...
seekingalpha.com/article/4663391-oxford-nanopore-ultra-long-reads-in-short-term-slump
Next
